Connect with us

Technology

Lumeris Partners With Schmitt-Thompson Clinical Content to Advance Tom™ Symptom-Checking Capability with Evidence-Based Telehealth Triage Guidance

Published

3 months ago

on

Partnership strengthens AI-powered symptom checking with trusted clinical content to support more consistent patient guidance and care navigation

CAMBRIDGE, Mass., and CHANDLER, Ariz., July 21, 2026 /PRNewswire/ — Lumeris, a leader in healthcare technology and services, and Schmitt-Thompson Clinical Content (STCC), the leading provider of telehealth triage guidelines and medical call center decision support information in North America, today announced a partnership to integrate STCC’s evidence-based clinical triage content into the symptom-checking capability within Tom™, Lumeris’ AI-powered Primary Care as a Service platform.

The partnership represents the next evolution of Tom’s ability to help care teams extend access, improve patient engagement and deliver more proactive support for individuals with complex health needs. By incorporating STCC’s clinical guidance, Tom’s symptom-checking capability provides healthcare organizations with a stronger clinical foundation for helping patients navigate symptoms between primary care visits while supporting more timely, informed interventions.

Patients with chronic conditions and other complex health needs frequently experience new symptoms, medication concerns or health-related questions between scheduled in-person primary care appointments. Without timely guidance from providers, they may delay care or seek treatment in higher-acuity settings that may not be necessary. Tom’s symptom-checking capability provides an accessible first point of contact, enabling patients and caregivers to report symptoms, ask health-related questions and receive support through natural, conversational interactions while helping care teams identify individuals who may require additional clinical attention.

The integration of STCC’s clinical content strengthens the guidance behind Tom’s symptom-checking experience, helping healthcare organizations deliver more standardized, evidence-based responses to symptom-based questions. By combining conversational patient engagement with trusted clinical decision support, organizations can improve consistency across care settings while helping care teams efficiently assess patient needs and determine appropriate next steps.

“One of the biggest challenges in caring for high-risk populations is making sure patients have access to the right support at the right time,” said Dr. David Carmouche, chief medical and commercial officer, Lumeris. “This partnership strengthens Tom’s role as an active member of the care team by combining conversational patient engagement with trusted clinical guidance. Together, we’re helping organizations deliver more consistent symptom assessment, streamline clinical workflows and support safer, more timely interventions.”

Following each symptom-checking interaction, Tom generates a structured summary along with recommended prioritization guidance to help care teams quickly assess patient needs and determine the most appropriate next actions. The capability complements clinical workflows rather than replaces them, allowing organizations to extend support beyond traditional care settings while maintaining appropriate clinical oversight.

The partnership further advances Lumeris’ vision for Tom as an intelligent extension of the primary care team, combining AI-powered patient engagement, evidence-based clinical guidance and care team workflows to help healthcare organizations improve access, enhance patient experiences and deliver more proactive, coordinated care.

“We’re excited to partner with Lumeris to bring our gold-standard clinical triage guidance to the Tom platform,” said Patty Maynard, chief operating officer, STCC. “Together, we’re enabling healthcare organizations to deliver symptom-checking experiences that combine conversational technology with evidence-based clinical decision support, helping patients receive more consistent guidance while supporting care teams with trusted recommendations they can confidently act on.”

About Lumeris
Lumeris is a leader in healthcare technology and services advancing the future of primary care through Tom, its AI-powered Primary Care as a Service platform designed to function as a proactive member of the care team embedded directly in clinical workflows. Tom autonomously supports best next actions that help providers expand capacity, improve patient access, and reduce administrative burden while enabling more personalized, scalable care delivery. Built on more than two decades of primary care and value-based care experience, Tom reflects Lumeris’ deep experience supporting health systems and physician organizations nationwide and operating Essence Healthcare, its leading Medicare Advantage plan. Founded in 2010, Lumeris is headquartered in St. Louis and Cambridge, Massachusetts. The company employs more than 1,200 engineers, clinicians, and healthcare specialists. Learn more at Lumeris.com.

About Schmitt-Thompson Clinical Content
Schmitt-Thompson Clinical Content (STCC) is the leading source of telehealth triage guidelines and medical call center decision support information in North America. STCC provides the most comprehensive triage and advice content, spanning the continuum of delivery: After Hours, used by hospitals, health systems and insurance companies and Office Hours, used in practices and clinics. Schmitt-Thompson Clinical Content is the ‘gold standard’ in telephone triage, offering evidence-based, efficient and time-tested decision support. It is used by more than 400 health systems and health plans and an additional 10,000 physician practices. Learn more: http://www.stcc-triage.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lumeris-partners-with-schmitt-thompson-clinical-content-to-advance-tom-symptom-checking-capability-with-evidence-based-telehealth-triage-guidance-302829780.html

SOURCE Lumeris

Related Topics:
Continue Reading

Technology

AstroRad Vest Worn by Astronauts Aboard International Space Station to Go on Display at Smithsonian National Air and Space Museum

Published

48 minutes ago

on

October 30, 2026

By

The historic exhibition follows landmark radiation protection findings from NASA’s Artemis I mission, whose AstroRad vest is separately displayed at Kennedy Space Center.

TAMPA, Fla., Oct. 30, 2026 /PRNewswire/ — StemRad, a developer of advanced radiation protection technology, shared that one of its AstroRad radiation protection vests, flown aboard the International Space Station (ISS) and worn by five space travelers, will go on display in the At Home in Space gallery at the Smithsonian’s National Air and Space Museum in Washington, D.C.

The vest was worn by four female American astronauts and an Israeli private astronaut during everyday activities aboard the ISS, including work and sleep. These in-orbit evaluations provided valuable experience with the practicality and comfort of wearable radiation protection during extended space missions.

The Smithsonian exhibition follows the recent publication of landmark scientific findings in Science Advances from NASA’s Artemis I mission. The research demonstrated AstroRad’s ability to dramatically reduce radiation exposure during potentially cancer-inducing solar radiation storms: for the August 1972 storm, which occurred between Apollo 16 and 17, a 60% reduction in dose was demonstrated (roughly 1,200 chest X-rays). This provided important evidence for protecting astronauts on future missions to the Moon and Mars.

The AstroRad vest that traveled around the Moon aboard Artemis I is separately on display at NASA’s Kennedy Space Center Visitor Complex in Florida. Together, the two exhibits trace AstroRad’s journey from operational evaluations aboard the ISS to radiation protection research beyond Earth’s magnetic field.

“Having AstroRad displayed at the Smithsonian is a tremendous honor and a proud milestone for our team,” said Dr. Oren Milstein, CEO and Co-Founder of StemRad. “Knowing that a technology we developed to help protect astronauts is now being recognized as part of the history of space exploration is incredibly rewarding. With AstroRad also on display at Kennedy Space Center following the groundbreaking Artemis I mission, we hope these exhibits will inspire future generations to tackle the challenges of human space exploration.”

“The AstroRad vest helps tell two stories in the new At Home in Space exhibit,” said Dr. Jennifer Levasseur, Museum Curator, and the lead curator for the gallery. “Importantly, the vest represents efforts to protect astronauts from the significant concern of increased radiation exposure on long duration spaceflights. It’s also an example of how technology demonstrations on the ISS will inform future human deep space exploration.” AstroRad was developed by StemRad in collaboration with Lockheed Martin to address one of the principal challenges of human space exploration: exposure to harmful ionizing radiation. The ISS operational evaluations, the Artemis I scientific results, and the Smithsonian and Kennedy Space Center exhibitions collectively highlight the growing role of wearable radiation protection in the future of human spaceflight.

About StemRad

StemRad is an American-Israeli company specializing in personal radiation protection technologies. Its solutions are designed to protect critical organs and tissues from harmful ionizing radiation while preserving mobility and operational effectiveness. StemRad develops radiation protection solutions for space exploration, emergency response, and defense applications.

Media Contact
StemRad
Tamar Cohen
+1-813-291-2303
425954@email4pr.com
www.stemrad.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/astrorad-vest-worn-by-astronauts-aboard-international-space-station-to-go-on-display-at-smithsonian-national-air-and-space-museum-302925068.html

SOURCE StemRad

Continue Reading

Technology

Three Products Featuring TCL CSOT Displays Named to TIME’s Best Inventions of 2026

Published

48 minutes ago

on

October 30, 2026

By

SHENZHEN, China, Oct. 30, 2026 /PRNewswire/ — TCL’s flagship X11L SQD-Mini LED TV, the XTEINK X4 Pro Pocket eReader and the Framework Laptop 13 Pro have been named to TIME’s Best Inventions of 2026 list. All three products feature displays supplied by TCL CSOT.

TCL X11L: Advancing Large-Screen Picture Quality

As the only Chinese TV selected in the consumer electronics category of TIME’s Best Inventions of 2026, the TCL X11L features the TCL CSOT WHVA 2.0 Ultra Panel, delivering a native contrast ratio of 7,000:1 and 100% BT.2020 color space coverage. Its display technology combines the TCL CSOT Ultra Color Filter with 20,736 Precise Dimming Zones and 10,000-nit peak HDR brightness. Powered by SQD-Mini LED technology, which delivers an industry-leading color gamut, the X11L captures subtle variations in light, further advancing large-screen picture quality.

In its Best Inventions of 2026 coverage, TIME noted that “those who manufacture TVs are constantly seeking new ways to one-up their competitors, either through unique design or unmatchable image quality.” The TCL X11L, the publication stated, “promises the latter with an LED panel that employs ‘super quantum dot’ technology, designed with the capacity to emit light at more specific nanometer wavelengths than previously available tech. The resulting image is extremely color accurate but also impressively bright.”

XTEINK X4 Pro: Bringing Reading to Your Pocket

The XTEINK X4 Pro features a 4.3-inch E Ink display that uses reflective imaging technology and emits no blue light, delivering a paper-like reading experience designed to reduce eye fatigue during extended use. Its capacitive touchscreen and adjustable warm-and-cool front lighting help provide comfortable reading conditions throughout the day and night.

TIME wrote, “While the most popular e-readers are smaller than a hardcover, many are still a bit too large for true grab-and-go convenience. XTEINK filled the gap with its X3 and X4 e-readers.” Beyond its compact size, the XTEINK X4 Pro further enhances the reading experience with an upgraded, higher-capacity battery, making pocket-sized reading convenient at any time of day or night.

Framework Laptop 13 Pro: A Repairable, Upgradeable Laptop

The Framework Laptop 13 Pro combines a modular, repairable design with a custom 13.5-inch 2.8K touchscreen supplied by TCL CSOT. The display module measures 2.0 mm thick on the device side and 2.1 mm on the PCB side, with a weight of only 180 g, supporting the laptop’s modular architecture. The updated model also features a 74 Wh battery and a haptic trackpad, while its modular design allows users to replace or upgrade components and customize their configuration, from memory and keyboard options to ports.

TIME recognized the laptop for making high-performance computing more repairable and user-customizable. The newly updated Framework Laptop 13 Pro is more “like a bicycle,” says Framework CEO Nirav Patel. “Every part is easy to replace.” With an included screwdriver and components designed for replacement and upgrades, the laptop enables users to repair and personalize their devices themselves, and help extend product lifespan. By putting repair and customization in users’ hands, the Framework Laptop 13 Pro offers a more flexible and sustainable approach to personal computing.

The inclusion of all three products in TIME’s Best Inventions of 2026 highlights not only the strength of each product, but also TCL CSOT’s end-to-end capabilities from technology R&D to industry collaboration. Looking ahead, TCL CSOT will continue to advance multiple display technology pathways and collaborate with industry partners to expand applications across diverse scenarios, bringing high-quality, slim, eye-care and environmentally friendly display solutions to more users.

SOURCE TCL CSOT

Continue Reading

Technology

Bybit Brings Its New Financial Platform Vision to Hong Kong FinTech Week 2026

Published

48 minutes ago

on

October 30, 2026

By

LISBON, Portugal, Oct. 30, 2026 /PRNewswire/ — Bybit, the New Financial Platform trusted by more than 80 million users worldwide, announced its participation in Hong Kong FinTech Week (HKFTW) 2026, Asia’s premier fintech summit bringing together global financial leaders, regulators, and innovators at the Hong Kong Convention and Exhibition Centre from November 2 to 6, 2026.

Bybit’s senior leadership will take the stage during the two-day main conference, joining more than 1,000 global speakers and 45,000 participants from over 120 economies at one of the year’s most anticipated events for changemakers in financial services and innovation.

Ben Zhou, Co-founder and CEO of Bybit, will deliver a fireside chat on the Main Stage on November 3 titled “Bridging the Divide: The Next Chapter of TradFi & Crypto Convergence.” The session will explore how AI-driven platform innovation, institutional-grade infrastructure and asset tokenization are reshaping the boundary between traditional financial markets and the digital asset ecosystem.

Sean Ballard, Head of Derivatives and Institutional Business at Bybit, will join a panel discussion titled “The Future of Trading: Next-Generation Market Infrastructure and Liquidity” alongside executives from Panthertrade, Gravity Team and BitGo on November 3. The panel will examine how AI-driven execution models, tokenized market access, and synchronized liquidity pools are converging to create more resilient, capital-efficient and accessible trading infrastructure for professional market participants.

Themed “Fintech Nexus: Bridging the World, Building the Future”, HKFTW 2026 is organized around three strategic engines: Finance+, AI+, and Go Global, reflecting the city’s role as a super-connector between capital, innovation and international markets. The event features 10 dedicated forums, including the Digital Assets and Web3 Forum and the AI in Finance Forum, with keynote speakers from leading global financial institutions and regulators.

Bybit is not licensed by the Hong Kong Securities and Futures Commission, and its services are not available to the public in Hong Kong.

About Bybit

Bybit is The New Financial Platform.

We believe every person should have access to every financial opportunity on earth. That’s why we’re building the first intelligent platform that connects anyone, anywhere to the world’s finance.

Trusted by more than 80 million users worldwide, Bybit brings together investing, trading, payments, and wealth-building in a single secure and intelligent ecosystem. Through the combination of AI-powered technology, deep global liquidity, robust security, and transparent operations, Bybit makes global finance more accessible, efficient, and empowering for everyone.

Built for everyone. Powered by intelligence. Open to the world.

Learn more at Bybit.com.
For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: media@bybit.com
Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | YouTube

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/bybit-brings-its-new-financial-platform-vision-to-hong-kong-fintech-week-2026-302925078.html

SOURCE Bybit

Continue Reading

Trending